General Information of Drug (ID: DMZ3QHF)

Drug Name
CB-102930 Drug Info
Synonyms Antimicrobials, Cubist; CB-193; CB-286; CB-432; CB-447; CB-454; CB-484; CB-545; CB-628; CB-629; TRNA synthetase inhibitors (antimicrobial); TRNA synthetase inhibitors (antimicrobial), Cubist
Indication
Disease Entry ICD 11 Status REF
Bacterial infection 1A00-1C4Z Terminated [1]
Cross-matching ID
TTD Drug ID
DMZ3QHF

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Icofungipen DMTXNZK Fungal infection 1F29-1F2F Phase 2 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fungal Isoleucyl t-RNA synthetase (Fung ILS1) TTBZHDM SYIC_YEAST Inhibitor [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016793)
2 Prospects for Aminoacyl-tRNA Synthetase Inhibitors as New Antimicrobial Agents. Antimicrob Agents Chemother. 2005 December; 49(12): 4821-4833.
3 Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits. Antimicrob Agents Chemother. 2005 May;49(5):2084-92.